Greentank Technologies, a leading R&D firm specializing in electronic vaporization technologies, has secured $16.5 million in Series B funding from investor Organigram Inc. The Toronto-based company is dedicated to providing high-quality, customizable vaporization hardware that brings its customers' unique visions to life.

One of the advantages of Greentank is its proprietary ceramic formulations, which enable the company to design, develop, and manufacture vaporization hardware that stands out in the market. Greentank also boasts the most in-depth customization possibilities in the industry and takes a hands-on approach to its customers' unique formulations. Additionally, the company has strategic manufacturing partnerships, sources only the highest-grade materials, and has rigorous quality control and quality assurance processes.

The funding will allow Greentank to continue investing in innovation and product development, further solidifying its position as an electronic vaporization technology industry leader. The company is committed to providing the most dependable and highest-quality vaporization hardware on the market while prioritizing sustainability and social responsibility.

With the support of Organigram Inc, Greentank is well-positioned to expand its reach and continue to provide innovative solutions to its customers. The Series B funding will help the company achieve its goals and remain at the forefront of the electronic vaporization technology industry. Visit us for more information about our latest funding round: https://founderlodge.com/round/Greentank-Technologies-raises-16500000-Series-B-2023-04-03-Dustin-Koffler-MTE4NjM